Author Cleland, John G.

• 2016 | Journal Article
  ​ ​A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF​
  Voors, A. A.; Anker, S. D. ; Cleland, J. G.; Dickstein, K.; Filippatos, G.; van der Harst, P. & Hillege, H. L. et al.​ (2016) 
  European Journal of Heart Failure, 18(6) pp. 716​-726​.​ DOI: https://doi.org/10.1002/ejhf.531 
  ​Details  DOI 

• 2017 | Journal Article
  ​ ​Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure​
  Voors, A. A.; Ouwerkerk, W.; Zannad, F.; van Veldhuisen, D. J.; Samani, N. J.; Ponikowski, P. & Ng, L. L. et al.​ (2017) 
  European Journal of Heart Failure, 19(5) pp. 627​-634​.​ DOI: https://doi.org/10.1002/ejhf.785 
  ​Details  DOI 

• 2017 | Journal Article
  ​ ​Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF​
  Ferreira, J. P.; Rossignol, P.; Machu, J.-L.; Sharma, A.; Girerd, N.; Anker, S. D.   & Cleland, J. G. et al.​ (2017) 
  European Journal of Heart Failure, 19(10) pp. 1284​-1293​.​ DOI: https://doi.org/10.1002/ejhf.900 
  ​Details  DOI 

• 2017 | Journal Article
  ​ ​The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure​
  Bayes-Genis, A.; Núñez, J.; Zannad, F.; Ferreira, J. P.; Anker, S. D. ; Cleland, J. G. & Dickstein, K. et al.​ (2017) 
  Journal of the American College of Cardiology, 70(17) pp. 2128​-2136​.​ DOI: https://doi.org/10.1016/j.jacc.2017.08.057 
  ​Details  DOI 

• 2017 | Journal Article
  ​ ​Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure​
  Emmens, J. E.; Jones, D. J.; Cao, T. H.; Chan, D. C.; Romaine, S. P.; Quinn, P. A. & Anker, S. D.  et al.​ (2017) 
  European Journal of Heart Failure, 20(2) pp. 260​-267​.​ DOI: https://doi.org/10.1002/ejhf.1101 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction​
  Streng, K. W.; Nauta, J. F.; Hillege, H. L.; Anker, S. D. ; Cleland, J. G.; Dickstein, K. & Filippatos, G. et al.​ (2018) 
  International Journal of Cardiology, 271 pp. 132​-139​.​ DOI: https://doi.org/10.1016/j.ijcard.2018.04.001 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF​
  Beusekamp, J. C.; Tromp, J.; van der Wal, H. H.; Anker, S. D. ; Cleland, J. G.; Dickstein, K. & Filippatos, G. et al.​ (2018) 
  European Journal of Heart Failure, 20(5) pp. 923​-930​.​ DOI: https://doi.org/10.1002/ejhf.1079 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how?​
  Dickstein, K.; Normand, C.; Auricchio, A.; Bogale, N.; Cleland, J. G.; Gitt, A. K. & Stellbrink, C. et al.​ (2018) 
  European Journal of Heart Failure, 20(6) pp. 1039​-1051​.​ DOI: https://doi.org/10.1002/ejhf.1142 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure​
  ter Maaten, J. M.; Voors, A. A.; Damman, K.; van der Meer, P.; Anker, S. D.; Cleland, J. G. & Dickstein, K. et al.​ (2018) 
  International Journal of Cardiology, 253 pp. 84​-90​.​ DOI: https://doi.org/10.1016/j.ijcard.2017.10.010 
  ​Details  DOI 

• 2018 | Journal Article | Research Paper
  ​ ​Treatments targeting inotropy​
  Maack, C.; Eschenhagen, T. ; Hamdani, N.; Heinzel, F. R.; Lyon, A. R.; Manstein, D. J. & Metzger, J. et al.​ (2018) 
  European Heart Journal, art. ehy600​.​ DOI: https://doi.org/10.1093/eurheartj/ehy600 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article
  ​ ​Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study​
  Ferreira, J. P.; Metra, M.; Anker, S. D. ; Dickstein, K.; Lang, C. C.; Ng, L. & Samani, N. J. et al.​ (2019) 
  European Journal of Heart Failure, 21(2) pp. 218​-226​.​ DOI: https://doi.org/10.1002/ejhf.1380 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure: results from BIOSTAT‐CHF​
  Suzuki, T.; Yazaki, Y.; Voors, A. A.; Jones, D. J.; Chan, D. C.; Anker, S. D.   & Cleland, J. G. et al.​ (2019) 
  European Journal of Heart Failure, 21(7) pp. 877​-886​.​ DOI: https://doi.org/10.1002/ejhf.1338 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​What do patients with heart failure die from? A single assassin or a conspiracy?​
  Anker, M. S.; Hülsmann, M. & Cleland, J. G.​ (2019) 
  European Journal of Heart Failure, 22(1) pp. 26​-28​.​ DOI: https://doi.org/10.1002/ejhf.1689 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study​
  Markousis‐Mavrogenis, G.; Tromp, J.; Ouwerkerk, W.; Devalaraja, M.; Anker, S. D. ; Cleland, J. G. & Dickstein, K. et al.​ (2019) 
  European Journal of Heart Failure, 21(8) pp. 965​-973​.​ DOI: https://doi.org/10.1002/ejhf.1482 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Geographical location affects the levels and association of trimethylamine N‐oxide with heart failure mortality in BIOSTAT‐CHF: a post‐hoc analysis​
  Yazaki, Y.; Salzano, A.; Nelson, C. P.; Voors, A. A.; Anker, S. D. ; Cleland, J. G. & Lang, C. C. et al.​ (2019) 
  European Journal of Heart Failure, 21(10) pp. 1291​-1294​.​ DOI: https://doi.org/10.1002/ejhf.1550 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation​
  Mordi, I. R.; Santema, B. T.; Kloosterman, M.; Choy, A.-M.; Rienstra, M.; van Gelder, I. & Anker, S. D. et al.​ (2019) 
  Clinical Research in Cardiology, pp. 1​-9​.​ DOI: https://doi.org/10.1007/s00392-018-1409-x 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article
  ​ ​Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life​
  Bekfani, T.; Pellicori, P.; Morris, D.; Ebner, N. ; Valentova, M. ; Sandek, A.   & Doehner, W. et al.​ (2019) 
  Clinical Research in Cardiology, 108(2) pp. 203​-211​.​ DOI: https://doi.org/10.1007/s00392-018-1344-x 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article | 
  ​ ​Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology​
  de Boer, R. A.; De Keulenaer, G.; Bauersachs, J.; Brutsaert, D.; Cleland, J. G.; Diez, J. & Du, X. et al.​ (2019) 
  European Journal of Heart Failure, 21(3) pp. 272​-285​.​ DOI: https://doi.org/10.1002/ejhf.1406 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article
  ​ ​Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study​
  Lombardi, C. M.; Ferreira, J. P.; Carubelli, V.; Anker, S. D. ; Cleland, J. G.; Dickstein, K. & Filippatos, G. et al.​ (2020) 
  Clinical Research in Cardiology, 109(8) pp. 967​-977​.​ DOI: https://doi.org/10.1007/s00392-019-01588-7 
  ​Details  DOI 

• 2020 | Journal Article
  ​ ​Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF​
  Kobayashi, M.; Voors, A. A.; Girerd, N.; Billotte, M.; Anker, S. D. ; Cleland, J. G. & Lang, C. C. et al.​ (2020) 
  European Journal of Internal Medicine, 71 pp. 62​-69​.​ DOI: https://doi.org/10.1016/j.ejim.2019.10.017 
  ​Details  DOI 

Researcher

Sort

Items per Page